Unknown PHASE4 INTERVENTIONAL 2-arm NCT01346436

Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction

Randomized Double Blind Controlled Trial of the Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction

Sponsor: Nicolas C. Buchs

Conditions Pelvic Organ Prolapse Rectal Prolapse

Interventions Minimally invasive rectopexy

Updated 6 times since 2017 Last updated: May 4, 2017 Started: Apr 30, 2011 Primary completion: May 31, 2020 Completion: May 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pelvic Organ Prolapse and Rectal Prolapse and is currently ongoing. Nicolas C. Buchs leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Jun 2020 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nicolas C. Buchs

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Geneva, Switzerland